-
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by Analysts
Source: Buzz FX / 14 Nov 2024 02:11:19 America/Chicago
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat November 14, 2024 Share Link copied to clipboard. Shares of Crinetics Pharmaceuticals, Inc.
Read more...